普瑞眼科
(301239)
| 流通市值：35.62亿 | | | 总市值：75.29亿 |
| 流通股本：7078.95万 | | | 总股本：1.50亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,166,125,568.45 | 1,377,971,782.3 | 649,826,753.5 | 1,725,640,393.39 |
| 营业收入 | 2,166,125,568.45 | 1,377,971,782.3 | 649,826,753.5 | 1,725,640,393.39 |
| 二、营业总成本 | 1,846,235,666.59 | 1,169,426,604.49 | 549,611,128.83 | 1,677,711,083.92 |
| 营业成本 | 1,179,555,373.73 | 752,656,658.3 | 359,754,749.9 | 1,006,521,752.06 |
| 税金及附加 | 4,154,059.33 | 2,172,950.62 | 615,679.09 | 3,192,517.05 |
| 销售费用 | 346,451,019.62 | 217,290,674.51 | 97,482,987.19 | 343,533,035.06 |
| 管理费用 | 262,937,736.3 | 163,856,623.06 | 76,632,490.44 | 270,308,308.52 |
| 研发费用 | 7,155,122.27 | 4,865,185.43 | 2,211,420.12 | 6,644,826.66 |
| 财务费用 | 45,982,355.34 | 28,584,512.57 | 12,913,802.09 | 47,510,644.57 |
| 其中:利息费用 | 54,327,555.72 | 33,882,354.37 | 16,779,388.3 | 57,563,416.04 |
| 其中:利息收入 | - | 8,586,948.93 | 4,498,891.13 | 14,368,966.29 |
| 加:投资收益 | 92,579,390.96 | 92,783,294.14 | 92,054,220.2 | 15,168,554.39 |
| 资产处置收益 | 40,085.4 | 6,002.6 | 8,812.78 | 564,384.43 |
| 资产减值损失(新) | -1,287,662.38 | -785,911.77 | -315,186.53 | -3,023,593.83 |
| 信用减值损失(新) | -4,491,832.02 | -3,596,977.53 | -2,907,501.3 | -3,036,190.85 |
| 其他收益 | 12,360,128.11 | 6,398,330.73 | 2,418,412.98 | 9,935,001.63 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 419,090,011.93 | 303,349,915.98 | 191,474,382.8 | 67,537,465.24 |
| 加:营业外收入 | 329,291.13 | 241,245.88 | 77,546.48 | 383,590.05 |
| 减:营业外支出 | 15,247,872.91 | 10,736,204.95 | 2,238,599.1 | 8,695,777.19 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 404,171,430.15 | 292,854,956.91 | 189,313,330.18 | 59,225,278.1 |
| 减:所得税费用 | 78,428,960.14 | 52,478,067.05 | 23,978,782.96 | 38,657,077.21 |
| 六、净利润 | 325,742,470.01 | 240,376,889.86 | 165,334,547.22 | 20,568,200.89 |
| 持续经营净利润 | 325,742,470.01 | 240,376,889.86 | 165,334,547.22 | 20,568,200.89 |
| 归属于母公司股东的净利润 | 317,242,547.43 | 234,826,276.55 | 162,393,315.01 | 20,568,200.89 |
| 少数股东损益 | 8,499,922.58 | 5,550,613.31 | 2,941,232.21 | - |
| (一)基本每股收益 | 2.12 | 1.57 | 1.09 | 0.16 |
| (二)稀释每股收益 | 2.12 | 1.57 | 1.09 | 0.16 |
| 八、其他综合收益 | - | - | - | -282,989.31 |
| 归属于母公司股东的其他综合收益 | - | - | - | -282,989.31 |
| 九、综合收益总额 | 325,742,470.01 | 240,376,889.86 | 165,334,547.22 | 20,285,211.58 |
| 归属于母公司股东的综合收益总额 | 317,242,547.43 | 234,826,276.55 | 162,393,315.01 | 20,285,211.58 |
| 归属于少数股东的综合收益总额 | 8,499,922.58 | 5,550,613.31 | 2,941,232.21 | - |
| 公告日期 | 2023-10-30 | 2023-08-30 | 2023-04-26 | 2023-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |